BioLargo, Inc.Insider Ownership
|
|
Current Insider Ownership
Log in to see the full results
Login or create a free CapEdge account to unlock the rest of this table.
| Code Kenneth Reay | Chief Science Officer | Common stockCommon Stock | Dec 31, 2024Jul 7, 2026 | 25,120,24526,408,319 | 7.838.23 | 2,763,2272,904,915 |
| Calvert Dennis P | President | Common stockCommon Stock | Dec 31, 2023Jul 1, 2026 | 9,860,04411,058,108 | 3.073.45 | 1,084,6051,216,392 |
| Dargan Charles K | Chief Financial Officer | OptionOption to purchase common stockOption to Purchase Common Stock | Aug 13, 2024Jun 23, 2024Feb 1, 2026 | 4,625,78612,847,1799,963,168 | 1.444.003.10 | 508,8361,413,1901,095,948 |
Insider Trading Trends
Insider Transactions
Voluntary Buys vs Sells
You need to login to see this data
Historical Insider Trading (3-Years)
10b5-1
Log in to see the full results
Login or create a free CapEdge account to unlock the rest of this table.
| Code Kenneth Reay | Common Stock | No | No | Grant | ACQUIRE A | 0.11 | +532,567 | 60,446 | 26,408,319 | Jul 7, 2026 | |
| Calvert Dennis P | Common Stock | No | No | Grant | ACQUIRE A | 0.11 | +219,914 | 24,850 | 11,058,108 | Jul 1, 2026 | |
| Strommen Jack B. | Common Stock | No | No | Grant | ACQUIRE A | 0.11 | +132,159 | 15,000 | 2,584,262 | Jun 30, 2026 | |